(Q43932951)

28 November 2017

title

Serum procollagen III peptide levels in subjects with sarcoidosis. A 5-year follow-up study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1310576

11 September 2022

Serum Procollagen III Peptide Levels in Subjects with Sarcoidosis: A 5-Year Follow-up Study (English)

1 reference

https://api.crossref.org/works/10.1164/AJRCCM/145.2_PT_1.412

1 December 2023

author name string

Pohl WR

1

1 reference

28 November 2017

Thompson AB

2

1 reference

28 November 2017

Köhn H

3

1 reference

28 November 2017

Losch S

4

1 reference

28 November 2017

Umek H

5

1 reference

28 November 2017

Legenstein E

6

1 reference

28 November 2017

Kummer F

7

1 reference

28 November 2017

Rennard SI

8

1 reference

28 November 2017

Klech H

9

1 reference

28 November 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1310576

11 September 2022

publication date

1 February 1992

1 reference

The American Review of Respiratory Disease

28 November 2017

published in

1 reference

28 November 2017

volume

145

1 reference

28 November 2017

issue

2 Pt 1

1 reference

28 November 2017

page(s)

412-417

1 reference

Biosynthesis of Procollagen

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F145.2_PT_1.412

Cryptogenic fibrosing alveolitis: prediction of fibrogenic activity from immunohistochemical studies of collagen types in lung biopsy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F145.2_PT_1.412

The roentgenographic staging of sarcoidosis. Historic and contemporary perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F145.2_PT_1.412

Radioimmunoassay for type III procollagen peptide and its application to human liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F145.2_PT_1.412

Lung collagen: more than scaffolding

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F145.2_PT_1.412

Fibrotic reactions in the lung: the activation of the lung fibroblast

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F145.2_PT_1.412

An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F145.2_PT_1.412

Interstitial lung disease: current concepts of pathogenesis, staging and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F145.2_PT_1.412

Gallium-67 in the evaluation of sarcoidosis: correlations with serum angiotensin-converting enzyme and bronchoalveolar lavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F145.2_PT_1.412

Elevation of serum angiotension-converting-enzyme (ACE) level in sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F145.2_PT_1.412

Fibronectin and procollagen 3 levels in bronchoalveolar lavage of asbestos-exposed human subjects and sheep

21 January 2018

4

1 reference

https://api.crossref.org/works/10.1164/AJRCCM/145.2_PT_1.412

The meaning and use of the area under a receiver operating characteristic (ROC) curve

1 December 2023

12

1 reference

https://api.crossref.org/works/10.1164/AJRCCM/145.2_PT_1.412

Release of amino-terminal procollagen peptides in paraquat-induced acute pulmonary fibrosis

1 December 2023

16

1 reference

https://api.crossref.org/works/10.1164/AJRCCM/145.2_PT_1.412

Clinical significance of pulmonary function tests. Pulmonary function testing in interstitial pulmonary disease. What does it tell us?

1 December 2023

19

1 reference

https://api.crossref.org/works/10.1164/AJRCCM/145.2_PT_1.412

Use of pulmonary function tests in the management of sarcoidosis

1 December 2023

21

1 reference

https://api.crossref.org/works/10.1164/AJRCCM/145.2_PT_1.412

Assessment of activity in Sarcoidosis. Sensitivity and specificity of 67Gallium scintigraphy, serum ACE levels, chest roentgenography, and blood lymphocyte subpopulations

1 December 2023

23

1 reference

https://api.crossref.org/works/10.1164/AJRCCM/145.2_PT_1.412

Comparison of gallium-67 scanning, bronchoalveolar lavage, and serum angiotensin-converting enzyme levels in pulmonary sarcoidosis. Predicting response to therapy

1 December 2023

25

1 reference

https://api.crossref.org/works/10.1164/AJRCCM/145.2_PT_1.412

1 December 2023

Identifiers

0 references

1 reference